Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Finasteride increases CD8+ T cells in BPH tissues.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

Tectona grandis leaf extracts, especially with propylene glycol, may be promising for topical hair loss treatments.

Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Testosterone helps human pancreatic cells increase insulin release.